EUVIMEDEUVIMED entdecken
Open Access

Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions

Mélissa Noack iD, Marlène Bailly, Laura Durix, Jean-Jacques Pin, Pierre Miossec

Clinical and Experimental Immunology · 2025

DOI: 10.1093/cei/uxaf047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Mélissa Noack und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunogenomics and Inflammation Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, France. Hauptthemen laut MEDLINE: Interleukin-17, Cell Communication, Histocompatibility Antigens Class II, Antigens, Differentiation, B-Lymphocyte. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Société Française de Rhumatologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Stromal-immune cell interactions promote pro-inflammatory cytokine secretion such as IL-17. IL-17 is involved in several chronic inflammatory diseases, affecting joints and skin. Podoplanin has been already identified as partially involved in high IL-17 secretion resulting from these cell interactions.

Methods

The aim of this study was to identify new molecules, using co-cultures of activated peripheral blood mononuclear cells and synoviocytes (5:1 ratio). Cell interactions were critical to induce a high IL-17 production. The blockade of podoplanin inhibited this production, approximately 40%, confirming the contribution of other molecules. A battery of mouse monoclonal anti-human RA synoviocyte antibodies were tested in co-cultures and several were selected for their inhibitory effect on IL-17.

Results

Cloning by expression allowed identifying the target of the selected 8350 antibody, a truncated isoform of CD74. CD74 blockade in co-cultures by 8350 antibody and a commercial antibody inhibited IL-17 production by 40%, but 8350 antibody had a limited effect on IL-10 inhibition. Furthermore, cell interactions increased CD74 expression, at mRNA and protein levels.

Conclusion

This study identified truncated CD74 isoform as a novel molecule directly involved in high IL-17 secretion resulting from cell interactions. Inhibition of this truncated CD74 could represent a new therapeutic option for diseases with IL-17 involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17Cell CommunicationHistocompatibility Antigens Class IIAntigens, Differentiation, B-LymphocyteLeukocytes, MononuclearSynoviocytesStromal CellsHumansCoculture TechniquesProtein IsoformsMembrane GlycoproteinsAnimalsInterleukin-10MiceCells, CulturedAntibodies, MonoclonalArthritis, RheumatoidPodoplanin

Stichwörter der Autor:innen

CD74IL-17 secretioncell interactions

Substanzen

Interleukin-17Protein IsoformsHistocompatibility Antigens Class IIAntigens, Differentiation, B-Lymphocyteinvariant chainMembrane GlycoproteinsInterleukin-10PDPN protein, humanAntibodies, MonoclonalPodoplanin

Autor:innen und Institutionen

  • Immunogenomics and Inflammation Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, France.
  • Eurobio Scientific, Hôpital Edouard Herriot, Lyon, France.

ORCID-Profile: Mélissa Noack

Förderung

  • Société Française de Rhumatologie

Zitieren

APA

Noack, M., Bailly, M., Durix, L., Pin, J. J., & Miossec, P. (2025). Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf047

Vancouver

Noack M, Bailly M, Durix L, Pin JJ, Miossec P. Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxaf047

BibTeX
@article{Noack2025,
  author = {Noack, Mélissa and Bailly, Marlène and Durix, Laura and Pin, Jean-Jacques and Miossec, Pierre},
  title = {Role of a new truncated CD74 isoform in increased IL-17 secretion from stromal-immune cell interactions},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  doi = {10.1093/cei/uxaf047}
}
Kostenlos starten →